Thrivent Financial for Lutherans
VRTX icon

Thrivent Financial for Lutherans’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$39.3M Buy
88,202
+1,119
+1% +$498K 0.09% 269
2025
Q1
$42.2M Sell
87,083
-817
-0.9% -$396K 0.09% 274
2024
Q4
$35.6M Sell
87,900
-3,775
-4% -$1.53M 0.07% 332
2024
Q3
$42.6M Sell
91,675
-3,119
-3% -$1.45M 0.08% 305
2024
Q2
$44.4M Buy
94,794
+5,827
+7% +$2.73M 0.09% 280
2024
Q1
$37.2M Buy
88,967
+27,602
+45% +$11.5M 0.07% 308
2023
Q4
$25M Sell
61,365
-14,266
-19% -$5.8M 0.05% 383
2023
Q3
$26.3M Sell
75,631
-27,585
-27% -$9.59M 0.06% 343
2023
Q2
$36.3M Buy
103,216
+30,041
+41% +$10.6M 0.08% 298
2023
Q1
$23.1M Sell
73,175
-22,002
-23% -$6.93M 0.06% 386
2022
Q4
$27.5M Sell
95,177
-137
-0.1% -$39.6K 0.07% 340
2022
Q3
$27.6M Sell
95,314
-8,259
-8% -$2.39M 0.08% 312
2022
Q2
$29.2M Sell
103,573
-1,299
-1% -$366K 0.08% 305
2022
Q1
$27.4M Buy
104,872
+52,466
+100% +$13.7M 0.05% 369
2021
Q4
$11.5M Buy
52,406
+8,056
+18% +$1.77M 0.02% 633
2021
Q3
$8.05M Sell
44,350
-1
-0% -$181 0.02% 741
2021
Q2
$8.94M Sell
44,351
-63
-0.1% -$12.7K 0.02% 721
2021
Q1
$9.54M Sell
44,414
-376,418
-89% -$80.9M 0.02% 673
2020
Q4
$99.5M Buy
420,832
+23,679
+6% +$5.6M 0.23% 107
2020
Q3
$108M Sell
397,153
-36,689
-8% -$9.98M 0.29% 73
2020
Q2
$126M Sell
433,842
-55,136
-11% -$16M 0.38% 48
2020
Q1
$116M Sell
488,978
-24,803
-5% -$5.9M 0.42% 40
2019
Q4
$112M Sell
513,781
-10,372
-2% -$2.27M 0.32% 66
2019
Q3
$88.8M Buy
524,153
+36,176
+7% +$6.13M 0.28% 91
2019
Q2
$89.5M Sell
487,977
-95,109
-16% -$17.4M 0.27% 82
2019
Q1
$107M Sell
583,086
-18,473
-3% -$3.4M 0.34% 62
2018
Q4
$99.7M Buy
601,559
+257,683
+75% +$42.7M 0.36% 56
2018
Q3
$66.3M Sell
343,876
-13,870
-4% -$2.67M 0.21% 118
2018
Q2
$60.8M Buy
357,746
+261,618
+272% +$44.5M 0.2% 122
2018
Q1
$15.7M Sell
96,128
-7,010
-7% -$1.14M 0.05% 349
2017
Q4
$15.5M Buy
103,138
+4,844
+5% +$726K 0.05% 344
2017
Q3
$14.9M Buy
98,294
+630
+0.6% +$95.8K 0.05% 320
2017
Q2
$12.6M Sell
97,664
-9,950
-9% -$1.28M 0.05% 331
2017
Q1
$11.8M Sell
107,614
-825,878
-88% -$90.3M 0.05% 341
2016
Q4
$68.8M Sell
933,492
-220,481
-19% -$16.2M 0.31% 84
2016
Q3
$101M Buy
1,153,973
+49,570
+4% +$4.32M 0.46% 45
2016
Q2
$95M Buy
1,104,403
+96,671
+10% +$8.32M 0.45% 46
2016
Q1
$80.1M Sell
1,007,732
-47,360
-4% -$3.76M 0.39% 57
2015
Q4
$133M Buy
1,055,092
+30,780
+3% +$3.87M 0.64% 38
2015
Q3
$107M Buy
1,024,312
+265,282
+35% +$27.6M 0.56% 39
2015
Q2
$93.7M Sell
759,030
-153,130
-17% -$18.9M 0.52% 44
2015
Q1
$108M Sell
912,160
-276,091
-23% -$32.6M 0.6% 36
2014
Q4
$141M Buy
1,188,251
+90,162
+8% +$10.7M 0.78% 25
2014
Q3
$123M Buy
1,098,089
+1,069,239
+3,706% +$120M 0.71% 32
2014
Q2
$2.73M Sell
28,850
-44,350
-61% -$4.2M 0.02% 635
2014
Q1
$5.18M Buy
73,200
+67,700
+1,231% +$4.79M 0.03% 434
2013
Q4
$409K Hold
5,500
﹤0.01% 1082
2013
Q3
$417K Sell
5,500
-399,320
-99% -$30.3M ﹤0.01% 1024
2013
Q2
$32.4K Buy
+404,820
New +$32.4K 0.21% 109